Prior and Concomitant Medications Dataset in Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections

Prior and concomitant medications taken by participant
Study Description
An open-label, multiple-dose study to determine the safety, tolerability, and pharmacokinetics of meropenem in preterm and term infants less than 91 days of age with suspected or confirmed intra-abdominal infections. Biospecimens are available.
Infants less than 91 days of age with suspected or confirmed intra-abdominal infection

受试者既往及合并用药情况
研究概况
本研究为一项开放标签、多剂量给药的临床试验，旨在探究美罗培南（meropenem）在疑似或确诊腹腔内感染、年龄小于91天的早产及足月婴儿中的安全性、耐受性与药代动力学（pharmacokinetics）特征。可提供生物样本（biospecimens）。
研究对象：年龄小于91天的疑似或确诊腹腔内感染婴儿